Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.80 USD
−4.71 B USD
6.84 B USD
342.77 M
About Moderna, Inc.
Sector
Industry
CEO
Stéphane Bancel
Website
Headquarters
Cambridge
Founded
2010
FIGI
BBG003PHHZT1
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
MRNA - long positionhi traders,
Let's have a look at MRNA stock on the weekly time frame.
As we can see, the price is retesting the COVID lows from 2020 which haven't been retested yet.
The RSI is very oversold and we believe that the trend reversal is likely.
Our strategy is to take a long position now around 55$.
MRNA earnings 11/7/24MRNA 2 day chart just printed a high probability long signal on the Fib TSI indicator yesterday. My speculation is that seasonally, it's a good idea to go long MRNA heading into the winter cold season. This is a simple trade entry based off the Fib TSI indicator long signal at 53. A round number ti
Potential massive reversal for MRNA?🔉Sound on!🔉
Thank you as always for watching my videos. I hope that you learned something very educational! Please feel free to like, share, and comment on this post. Remember only risk what you are willing to lose. Trading is very risky but it can change your life!
MRNA Set up for a Fast Rip to $87Flu season incoming, beginning of October to December
MRNA Set up for a retracement back up to $80-$87
$MRNA * MODERNA TC FIB EWP WEEKLY TF ANALYSISTechnical analysis of Moderna, Inc. (MRNA), using Elliott Wave Principle along with Fibonacci retracement levels. Here’s a breakdown of what I observe and what it might mean:
1. Elliott Wave Count : The chart features a labeled Elliott Wave pattern, with clear impulse waves and corrective waves (A
MRNA - Moderna, Inc.Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therap
Moderna (MRNA) Stock Plummets on Weak Sales OutlookModerna Inc. (NASDAQ: NASDAQ:MRNA ) is facing tough times as its stock dropped over 11% during Thursday’s premarket trading session. The biotech giant, known for its breakthrough COVID-19 vaccine, released a disappointing sales outlook for the upcoming years, sparking a significant sell-off among i
Buy NOW think later!!
1. Moderna is extremely oversold and we’re starting to see a very reliable bottoming pattern; i.e. bullish divergence on the RSI. This exact setup was seen few months back (see chart) and that’s how I called the bottom back then.
2. Given all the news about bird flu, not only does it put a floor u
Moderna Technical PerspectiveFrom a technical perspective, according to Moderna's weekly chart, sentiment is clearly to the downside in the long term. Following a test of support-turned-resistance at US$87.35, follow-through selling has emerged over the past few weeks. This has led price action within a stone’s throw of support
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where MRNA is featured.
Frequently Asked Questions
The current price of MRNA is 46.83 USD — it has decreased by −6.86% in the past 24 hours. Watch Moderna, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Moderna, Inc. stocks are traded under the ticker MRNA.
MRNA stock has fallen by −14.06% compared to the previous week, the month change is a −19.72% fall, over the last year Moderna, Inc. has showed a −34.72% decrease.
We've gathered analysts' opinions on Moderna, Inc. future price: according to them, MRNA price has a max estimate of 212.00 USD and a min estimate of 38.00 USD. Watch MRNA chart and read a more detailed Moderna, Inc. stock forecast: see what analysts think of Moderna, Inc. and suggest that you do with its stocks.
MRNA reached its all-time high on Aug 10, 2021 with the price of 497.49 USD, and its all-time low was 11.54 USD and was reached on Aug 7, 2019. View more price dynamics on MRNA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MRNA stock is 9.30% volatile and has beta coefficient of 0.32. Track Moderna, Inc. stock price on the chart and check out the list of the most volatile stocks — is Moderna, Inc. there?
Today Moderna, Inc. has the market capitalization of 18.02 B, it has increased by 3.64% over the last week.
Yes, you can track Moderna, Inc. financials in yearly and quarterly reports right on TradingView.
Moderna, Inc. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
MRNA earnings for the last quarter are 0.03 USD per share, whereas the estimation was −1.80 USD resulting in a 101.66% surprise. The estimated earnings for the next quarter are −2.62 USD per share. See more details about Moderna, Inc. earnings.
Moderna, Inc. revenue for the last quarter amounts to 1.86 B USD, despite the estimated figure of 1.25 B USD. In the next quarter, revenue is expected to reach 1.14 B USD.
MRNA net income for the last quarter is 13.00 M USD, while the quarter before that showed −1.28 B USD of net income which accounts for 101.02% change. Track more Moderna, Inc. financial stats to get the full picture.
No, MRNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 5.60 K employees. See our rating of the largest employees — is Moderna, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Moderna, Inc. EBITDA is −2.37 B USD, and current EBITDA margin is −53.01%. See more stats in Moderna, Inc. financial statements.
Like other stocks, MRNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Moderna, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Moderna, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Moderna, Inc. stock shows the sell signal. See more of Moderna, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.